A history of dopamine agonists. From the physiology and pharmacology of dopamine to therapies for prolactinomas and Parkinson’s disease – a subjective view

By Horowski R.  

Journal of Neural Transmission, Vol. 114, Iss. 1, 2007-01 ,pp. : 127-134

Springer Publishing Company

Access to resources Recommend Favorite

Conversion from dopamine agonists to pramipexole

By Linazasoro G.  

Journal of Neurology, Vol. 251, Iss. 3, 2004-03 ,pp. : 335-339

Springer Publishing Company

Access to resources Recommend Favorite

Dopamine Reduction of GABA Currents in Striatal Medium-sized Spiny Neurons is Mediated Principally by the D₁ Receptor Subtype

By Hernández-Echeagaray Elizabeth   Cepeda Carlos   Ariano Marjorie   Lobo Mary   Sibley David   Levine Michael  

Neurochemical Research, Vol. 32, Iss. 2, 2007-02 ,pp. : 229-240

Springer Publishing Company

Access to resources Recommend Favorite

Ca V subunit-mediated up-regulation of Ca V 2.2 currents triggered by D2 dopamine receptor activation

By Canti C.   Dolphin A.C.  

Neuropharmacology, Vol. 45, Iss. 6, 2003-11 ,pp. : 814-827

Elsevier

Access to resources Recommend Favorite

Zn 2+ modulates currents generated by the dopamine transporter: parallel effects on amphetamine-induced charge transfer and release

By Pifl C.   Rebernik P.   Kattinger A.   Reither H.  

Neuropharmacology, Vol. 46, Iss. 2, 2004-02 ,pp. : 223-231

Elsevier

Access to resources Recommend Favorite